Orion Infusion Limited (DSE: ORIONINFU)

Market Cap	6.19B
Revenue (ttm)	850.39M
Net Income (ttm)	42.70M
Shares Out	20.36M
EPS (ttm)	2.10
PE Ratio	144.98
Forward PE	n/a
Dividend	1.00 (0.33%)
Ex-Dividend Date	Dec 5, 2024

Volume	226,422
Open	n/a
Previous Close	311.50
Day's Range	300.00 - 326.80
52-Week Range	217.20 - 726.90
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2024

About Orion Infusion

Orion Infusion Limited engages in the manufacture and sale of large volume parenteral and other lifesaving injectable products in Bangladesh. It offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; Metronidazole I.V; pure steam generated fluids; and amino acids solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd. and changed its name to Orion Infusion Limited in 1994. Orion Infusion Limited was incorporated in 1983 and is based in Dhaka, Banglades...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1983
• Employees: 764
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONINFU

Financial Performance

In 2023, Orion Infusion's revenue was 810.15 million, a decrease of -2.34% compared to the previous year's 829.57 million. Earnings were 41.90 million, a decrease of -2.15%.